How is Canada’s vaccine safety and surveillance system being ramped up to monitor adverse events for the H1N1 flu vaccine?
The Public Health Agency of Canada (PHAC) is working with provinces and territories to produce weekly reports of all reported adverse events associated with the H1N1 flu vaccine. This reporting will be done through the existing system — the Canadian Adverse Events Following Immunization Reporting System (CAEFISS) . CAEFISS is supported by healthcare professionals who report adverse events to their provincial/territorial public health offices, who then share the information with PHAC. This existing system will be supported by additional projects that will provide more detailed data specifically about the H1N1 flu vaccine.
